Breakthrough fertility method may keep estrogen low during cancer treatment
NCT ID NCT03947151
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new ovarian stimulation protocol using degarelix (a drug typically used for prostate cancer) to help breast cancer patients preserve their fertility before chemotherapy. The goal was to keep estrogen levels low while still collecting enough eggs for freezing. The study included 8 women aged 18-40 with invasive ductal breast cancer who needed chemotherapy. Researchers measured how many follicles (egg sacs) developed and whether estrogen stayed at safe levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE DUCTAL BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Antoine Béclère
Clamart, 92140, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could freezing replace the scalpel for some breast cancers?
- Can a drug combo shrink breast tumors better before surgery?
- New radiation method may boost immune attack on tumors
- Cold sore virus turned cancer assassin shows promise in tough breast cancer
- New short radiation regimen aims to cut side effects in breast cancer treatment
- Could a short course of radiation before surgery spare more breast tissue?